tiprankstipranks
Trending News
More News >
Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
India Market
Advertisement

Orchid Pharma Limited (ORCHPHARMA) Ratios

Compare
0 Followers

Orchid Pharma Limited Ratios

IN:ORCHPHARMA's free cash flow for Q3 2025 was ₹0.43. For the 2025 fiscal year, IN:ORCHPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.83 3.04 3.04 1.35 1.87
Quick Ratio
1.68 2.03 2.03 0.73 1.15
Cash Ratio
0.07 0.01 0.01 0.06 0.02
Solvency Ratio
0.29 0.33 0.33 0.19 0.18
Operating Cash Flow Ratio
0.00 0.48 0.48 0.05 0.38
Short-Term Operating Cash Flow Coverage
0.00 8.97 8.97 0.10 1.55
Net Current Asset Value
₹ 3.87B₹ 4.06B₹ 4.06B₹ -355.48M₹ -132.97M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.09 0.09 0.27 0.24
Debt-to-Equity Ratio
0.14 0.12 0.12 0.48 0.41
Debt-to-Capital Ratio
0.12 0.10 0.10 0.32 0.29
Long-Term Debt-to-Capital Ratio
0.09 0.09 0.09 0.18 0.24
Financial Leverage Ratio
1.33 1.33 1.33 1.78 1.72
Debt Service Coverage Ratio
2.26 4.71 4.71 0.54 1.24
Interest Coverage Ratio
11.01 4.69 14.11 0.90 -1.06
Debt to Market Cap
0.05 0.03 0.03 0.21 0.23
Interest Debt Per Share
37.25 31.41 31.41 89.07 73.49
Net Debt to EBITDA
1.18 0.93 0.93 2.16 4.15
Profitability Margins
Gross Profit Margin
42.05%38.57%38.57%42.24%41.69%
EBIT Margin
11.22%13.22%13.22%13.14%-4.45%
EBITDA Margin
15.31%17.33%17.33%21.47%11.36%
Operating Profit Margin
18.52%9.58%28.83%4.35%-6.06%
Pretax Profit Margin
9.54%11.23%11.23%8.30%-10.17%
Net Profit Margin
10.02%11.25%11.25%6.96%-0.35%
Continuous Operations Profit Margin
10.02%11.61%11.61%7.97%-10.80%
Net Income Per EBT
105.00%100.24%100.24%83.84%3.43%
EBT Per EBIT
51.54%117.17%38.94%190.56%167.89%
Return on Assets (ROA)
5.05%5.93%5.93%3.78%-0.18%
Return on Equity (ROE)
6.98%7.88%7.88%6.73%-0.30%
Return on Capital Employed (ROCE)
11.23%6.06%18.25%3.40%-3.90%
Return on Invested Capital (ROIC)
10.68%6.20%18.66%1.48%-0.44%
Return on Tangible Assets
5.10%5.99%5.99%3.78%-0.18%
Earnings Yield
2.25%1.72%1.72%2.96%-0.17%
Efficiency Ratios
Receivables Turnover
3.52 4.09 4.19 3.09 3.28
Payables Turnover
2.22 2.19 2.19 2.21 1.95
Inventory Turnover
1.51 1.90 1.90 1.68 1.89
Fixed Asset Turnover
1.22 1.27 1.27 1.08 0.93
Asset Turnover
0.50 0.53 0.53 0.54 0.50
Working Capital Turnover Ratio
3.26 2.48 2.48 3.94 1.81
Cash Conversion Cycle
181.02 114.42 112.28 169.55 116.83
Days of Sales Outstanding
103.79 89.28 87.14 117.95 111.26
Days of Inventory Outstanding
241.72 191.66 191.66 217.07 193.14
Days of Payables Outstanding
164.48 166.53 166.53 165.47 187.58
Operating Cycle
345.51 280.95 278.81 335.02 304.40
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 26.05 26.05 4.55 22.66
Free Cash Flow Per Share
0.00 12.65 12.65 -16.25 19.13
CapEx Per Share
0.00 13.40 13.40 20.80 3.53
Free Cash Flow to Operating Cash Flow
0.00 0.49 0.49 -3.57 0.84
Dividend Paid and CapEx Coverage Ratio
0.00 1.94 1.94 0.22 6.42
Capital Expenditure Coverage Ratio
0.00 1.94 1.94 0.22 6.42
Operating Cash Flow Coverage Ratio
0.00 0.93 0.93 0.06 0.35
Operating Cash Flow to Sales Ratio
0.00 0.15 0.15 0.03 0.17
Free Cash Flow Yield
0.00%1.14%1.14%-4.24%6.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.45 58.06 58.06 33.77 -596.60
Price-to-Sales (P/S) Ratio
4.45 6.53 6.53 2.35 2.08
Price-to-Book (P/B) Ratio
2.99 4.58 4.58 2.27 1.80
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 87.47 87.47 -23.58 14.91
Price-to-Operating Cash Flow Ratio
0.00 42.47 42.47 84.18 12.59
Price-to-Earnings Growth (PEG) Ratio
-3.07 0.85 0.85 -0.01 6.07
Price-to-Fair Value
2.99 4.58 4.58 2.27 1.80
Enterprise Value Multiple
30.27 38.63 38.63 13.10 22.45
Enterprise Value
39.42B 54.82B 54.82B 18.73B 14.28B
EV to EBITDA
30.27 38.63 38.63 13.10 22.45
EV to Sales
4.64 6.69 6.69 2.81 2.55
EV to Free Cash Flow
0.00 89.62 89.62 -28.24 18.29
EV to Operating Cash Flow
0.00 43.51 43.51 100.79 15.44
Tangible Book Value Per Share
246.52 238.71 238.71 168.62 158.53
Shareholders’ Equity Per Share
249.88 241.80 241.80 168.72 158.61
Tax and Other Ratios
Effective Tax Rate
0.02 -0.03 -0.03 0.47 0.88
Revenue Per Share
167.69 169.35 169.35 163.14 137.09
Net Income Per Share
16.80 19.06 19.06 11.35 -0.48
Tax Burden
1.05 1.00 1.00 0.84 0.03
Interest Burden
0.85 0.85 0.85 0.63 2.29
Research & Development to Revenue
0.00 <0.01 <0.01 <0.01 0.01
SG&A to Revenue
0.00 0.01 0.01 0.01 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.37 1.37 0.40 -47.39
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis